Home›Research›Compare›Cartalax vs GHK-Cu
Peptide ComparisonCartalax vs GHK-Cu
Both are Skin & Cosmetic peptides.
Cartalax
Ala-Glu-Asp-Arg
Half-life: Unknown
7 providers listed
GHK-Cu
Copper Peptide
Half-life: 15–30 minutes
378 providers listed
GHK-Cu has published research citations on file; Cartalax does not yet — the main evidence gap between them.
Cartalax
Half-life
Unknown
GHK-Cu
Half-life
15–30 minutes
| Your goal | Better option |
|---|---|
| Has published research citations | GHK-Cu |
| Oral administration option | Cartalax |
| Lower typical price per mg | GHK-Cu |
| More provider options (7 vs 378) | GHK-Cu |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Cartalax
GHK-Cu
Cartalax
No citations on file.
GHK-Cu
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration th…
The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and ac…
Glycyl-L-histidyl-L-lysine-Cu2(+) (GHK-Cu) Attenuates CuSO(4) or LPS induced-inflammation in Zebrafish larvae…
+3 more
About Cartalax
Tetrapeptide bioregulator from cartilage tissue; stimulates chondrocyte proliferation and extracellular matrix synthesis; normalizes gene expression in cartilage cells
About GHK-Cu
GHK-Cu promotes the synthesis of collagen, elastin, glycosaminoglycans, and decorin, contributing to tissue remodelling and wound contraction. It modulates the activity of matrix metalloproteinases (MMPs) — stimulating wound-healing MMPs while suppressing those that degrade healthy tissue. Genomic analysis has identified GHK-Cu as a modulator of over 4,000 genes, including those governing antioxidant defences and anti-inflammatory pathways.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Cartalax
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
GHK-Cu
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
GHK-Cu
BPC-157
Research suggests GHK-Cu and BPC-157 may produce complementary tissue repair and anti-inflammatory effects when combined. GHK-Cu is studied for copper-dependent collagen synthesis and antioxidant gene activation, while BPC-157 supports angiogenesis and growth factor expression.
Epithalon
Research suggests Epithalon and GHK-Cu may produce complementary longevity-associated effects when combined. Epithalon is studied for telomere maintenance and pineal function, while GHK-Cu is studied for antioxidant gene expression and tissue remodeling — different mechanisms in aging research.
Cartalax
GHK-Cu
Where to source these peptides
Cartalax
7 listed
Browse directory →
Providers offeringGHK-Cu
378 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Skin & Cosmetic Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Cartalax vs GHK-Cu — Per-mg Price Comparison. Retrieved September 12, 2026, from https://peptidebase.io/peptides/compare/cartalax/ghk-cu